Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Influenza neuraminidase: A druggable target for natural products

25 Oct 2011

Abstract excerpt

The imminent threat of influenza pandemics and repeatedly reported emergence of new drug-resistant influenza virus strains demonstrate the urgent need for developing innovative and effective antiviral agents for prevention and treatment. At present, influenza neuraminidase (NA), a key enzyme in viral replication, spread, and pathogenesis, is considered to be one of the most promising targets for combating...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Protein Structure and Dynamics
Share to Influenza Virus Research Studies
Share to RNA and protein synthesis mechanisms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22025274
DOI: 10.1039/c1np00053e

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Influenza neuraminidase: A druggable target for natural productsPMID 22025274Read ↗

Influenza pharmacotherapy: present situation, strategies and hopes.Semantic proximity Read ↗

Identification of Novel and Efficacious Chemical Compounds that Disturb Influenza A Virus Entry in vitroSemantic proximity Read ↗

Novel Neuraminidase Inhibitors: Identification, Biological Evaluation and Investigations of the Binding ModeSemantic proximity Read ↗

The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design.Semantic proximity Read ↗

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014-2015.Semantic proximity Read ↗

Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistanceSemantic proximity Read ↗

Optimization of N-Substituted Oseltamivir Derivatives as Potent Inhibitors of Group-1 and -2 Influenza A Neuraminidases, Including a Drug-Resistant Variant.Semantic proximity Read ↗

Broad-Spectrum Antiviral Strategies and Nucleoside AnaloguesSemantic proximity Read ↗

Influenza Viruses: Harnessing the Crucial Role of the M2 Ion-Channel and Neuraminidase toward Inhibitor DesignSemantic proximity Read ↗

Identification of neuraminidase inhibitors against dual H274Y/I222R mutant strains.Semantic proximity Read ↗

Learning from structure-based drug design and new antivirals targeting the ribonucleoprotein complex for the treatment of influenzaSemantic proximity Read ↗

Structure and Activities of the NS1 Influenza Protein and Progress in the Development of Small-Molecule DrugsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.